Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Lung Cancer Clinical Trials in Austin | 199 Studies

Clinical Trials Lung CancerAustin

Lung Cancer Clinical Trials in Austin

Find 199 clinical trials for lung cancer near Austin, Texas. Connect with research centers in your area.

All Lung Cancer trials nationwide All trials in Austin

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 101-120 of 199 trials

CompletedA Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung CancerThe primary objective of the study is to compare overall survival of participants randomized to receiving custirsen in combination with docetaxel with participants randomized to…NCT01630733·Boynton Beach, Florida and 77 others

Lung Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedVolatile Anaesthesia and Perioperative Outcomes Related to Cancer: the VAPOR-C TrialVAPOR-C is a randomised study of the impact of IV versus inhaled anaesthesia (propofol versus sevoflurane) and lidocaine versus no lidocaine on duration of disease free survival…NCT04316013·Cleveland, Ohio and 26 others

TerminatedAVID100 in Advanced Epithelial CarcinomasApproximately 90 male and female patients with documented solid tumor malignancies of epithelial origin that are locally advanced or metastatic, and either refractory to standard…NCT03094169·New Haven, Connecticut and 9 others

CompletedDose Escalation and Expansion Study of FLX475 Monotherapy and in Combination With PembrolizumabThis clinical trial is a Phase 1/2, open-label, sequential-group, dose-escalation and cohort expansion study to determine the safety and preliminary anti-tumor activity of FLX475…NCT03674567·Gilbert, Arizona and 34 others

CompletedA Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive TumorsThis is a study to evaluate the effectiveness of erlotinib compared with a placebo sugar pill following complete surgical removal of the tumor with or without chemotherapy after…NCT00373425·Birmingham, Alabama and 294 others

Active not recruitingBeamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard TreatmentThis study is open to adults 18 years and older with advanced or metastatic non-small cell lung cancer.NCT06151574·Huntsville, Alabama and 162 others

CompletedPhase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung CancerThis study will compare the efficacy of the investigational agent sitravatinib in combination with nivolumab versus docetaxel in patients with advanced non-squamous NSCLC who have…NCT03906071·Birmingham, Alabama and 260 others

RecruitingA Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid TumorsThis is a Phase 1a/1b, dose-escalation/expansion, consecutive-cohort, open-label study to evaluate the safety, tolerability, PK, PD, and preliminary evidence of antitumor activity…NCT06270706·New Haven, Connecticut and 11 others

CompletedA Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.This is a study using sunitinib for patients ending treatment on a previous sunitinib malate protocol to continue to receive sunitinib.NCT00428220·Atlanta, Georgia and 112 others

CompletedA Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)This is a Phase IIIb, multicenter, randomized, placebo-controlled trial to evaluate the safety and efficacy of chemotherapy+bevacizumab followed by bevacizumab+erlotinib versus…NCT00257608·Mobile, Alabama and 246 others

Active not recruitingHERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI TherapyDisease progression is typical for patients with epidermal growth factor receptor mutated (EGFRm) non-small cell lung cancer (NSCLC).NCT05338970·Anchorage, Alaska and 181 others

CompletedAn Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced CancersA study to evaluate the safety of Nivolumab given in combination with Ipilimumab in patients with advanced cancers.NCT02869789·Birmingham, Alabama and 135 others

RecruitingA Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung CancerThe purpose of this study is to evaluate the efficacy and safety of divarasib and pembrolizumab compared with pembrolizumab and pemetrexed and carboplatin or cisplatin, for the…NCT06793215·Anchorage, Alaska and 279 others

CompletedIressa Versus Docetaxel (Taxotere)The purpose of this study is to compare the effects of ZD1839 or docetaxel in patients with advanced non-small cell lung cancer (NSCLC) that has recurred or progressed after…NCT00076388·Birmingham, Alabama and 161 others

CompletedA Global Study to Assess the Effects of MEDI4736 Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung CancerA Global Study to Assess the Effects of MEDI4736 following concurrent chemoradiation in Patients with Stage III Unresectable Non-Small Cell Lung Cancer.NCT02125461·Chandler, Arizona and 235 others

Active not recruitingStudy of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)This study will evaluate the efficacy, safety, and pharmacokinetics of DS-1062a versus docetaxel in participants with previously treated advanced or metastatic non-small cell lung…NCT04656652·Chandler, Arizona and 208 others

RecruitingClinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1Clinical study of ivonescimab for first-line treatment of metastatic NSCLC patients with high PD-L1. Evaluating overall survival and progression free survival.NCT06767514·Chandler, Arizona and 284 others

Active not recruitingA Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)The main objective of the study is to characterize safety and efficacy of 2 dose levels of anvumetostat by investigator, and to evaluate anvumetostat monotherapy efficacy by…NCT06593522·Duarte, California and 90 others

TerminatedMulticenter Study of Rociletinib Administered to Patients With Previously Treated Mutant EGFR Non-small Cell Lung CancerThe purpose of this study is to evaluate the safety and anti-tumor effect of rociletinib.NCT02147990·Alhambra, California and 90 others

CompletedHypofractionated Image-Guided Radiation Therapy (IGRT) in Patients With Stage II-III Non-Small Cell Lung CancerThe study is designed to determine whether an accelerated course of hypofractionated radiation therapy with daily image guidance and motion assessment/control will allow more…NCT01459497·Austin, Texas and 6 others

PreviousPage 6 of 10Next

Other Conditions in Austin

Breast Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma